Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

COVID Concerns Rise Amid Key Data Releases This Week

Published 11/29/2021, 03:50 AM
Updated 03/28/2023, 03:20 AM

Overnight Headlines
  • Markets Unwind Part Of Friday's Selloff As Variant Fears Ease
  • WHO Urges Caution As South Africa Calls Omicron Variant 'Mild'
  • Biden Told It Will Take Two Weeks For Definitive Omicron Data
  • US Black Friday Store Shopping Drops 28% From Pre-Covid Levels
  • ECB's Lagarde: Euro Zone In Better Shape Facing New Covid Wave
  • ECB's Panetta: ECB Doesn't Need To Intervene On Inflation For Now
  • France Wants To Work With the UK On Migration But Won't Be 'Hostage
  • England To Introduce New Omicron Restrictions From Tuesday
  • Japan Retail Sales Boosted By Fuel-Price Spike, Broad Trend Still Soft
  • Australia Q3 Inventories To Drag On GDP, Company Profits Rise
  • RBNZ Chief Economist Doesn't See Omicron Derailing Rate Increases
  • OPEC+ Moves Technical Meetings For Time To Review Market Rout

The Week Ahead

Uncertainty over Omicron variant to dominate markets. Investors were caught off-guard on Friday by the news that a potentially more contagious variant of the COVID-19 virus, with the propensity to re-infect, had been spreading quickly in southern African countries.

Factors that were previously driving market price action, such as economic data, normalization of monetary policy by major central banks, and inflation concerns, will now take a back seat to developments in the newly named Omicron variant.

It has since been detected in different parts of the world, and countries have already begun to tighten border restrictions. However, the World Health Organisation says it could take weeks to understand the level of severity of the variant. Federal Reserve Chair Jerome Powell and US Treasury Secretary Janet Yellen are due to speak this week, and the market will pay close attention to their take on the latest phase of the coronavirus pandemic.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

US jobs lead to a busy calendar, but COVID is in focus. There is a packed global economic data calendar this week, led by US nonfarm payrolls. Usually, the US jobs report and other top-tier data would help shape market direction. Still, concerns over the Omicron variant and government reactions will probably push the numbers into the background.

November nonfarm payrolls on Friday are expected to show a healthy 550,000 increase in jobs, according to the latest Reuters poll, while unemployment is seen easing to 4.5% from 4.6% in October. The closely watched average hourly earnings component is expected to rise 0.4% month-on-month, the same as October.

Other key US data includes ISM manufacturing and non-manufacturing, consumer confidence, factory orders, ADP employment, Chicago PMI and Case-Shiller home prices.

Europe's calendar includes Eurozone sentiment indices, final November PMIs and consumer confidence, flash HICP inflation data, October retail sales and unemployment. German inflation and unemployment are also due.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.